Key counseling points include: Therapy is aimed at preserving kidney and heart health Hydration and infection awareness with SGLT2 inhibitors Possible GI effects with GLP1 receptor agonists Cost, insurance coverage, and adherence strategies Use decision aids and refer patients to trusted resources like the National Kidney Foundation and patient materials on DiabetesInControl.com
When you eat, GLP-1 is released in your gut
Modeling the potential impact of incretin-based therapies as weight-loss and diabetes treatments on population morbidity and mortality trends The RGA model Quantifying potential impacts of incretin-based therapies on mortality and morbidity outcomes is difficult, given the many uncertainties at play
What if my powder looks different from what I expected
L., Chin, L., Wagner, G., Asara, J